NASDAQ · Analyst Forecast

MaxCyte, Inc. (MXCT) Analyst Forecast

$1.40 NASDAQ: MXCT Market Cap $144.49M

Revenue and earnings estimates published by analysts covering MaxCyte, Inc. (MXCT), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For MaxCyte, Inc., analysts forecast revenue rising from $38.15T in 2024 to $81.50T in 2029; the average estimate for 2029 earnings per share is $-0.11; with published estimates ranging from $-0.12 to $-0.10; 4 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

Measure	Value
Current priceWhat the share trades at now.	$1.40
Consensus targetThe average of the price targets analysts have published.	$6.00
Median targetThe middle target, less affected by a single outlier.	$6.00
Highest targetThe most optimistic published target.	$6.00
Lowest targetThe most pessimistic published target.	$6.00
Difference from priceHow far the consensus target sits from today’s price.	+328.6%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD millions)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

Year	Low	Average	High	Analysts
2024	$36.28T	$38.15T	$40.07T	4
2025	$34.68T	$35.12T	$35.57T	3
2026	$30.62T	$32.20T	$33.83T	4
2027	$35.41T	$37.23T	$39.12T	4
2028	$34.38T	$38.83T	$43.28T	2
2029	$77.50T	$81.50T	$85.62T	1

Earnings per share forecast

Year	Low	Average	High	Analysts
2024	$-0.42	$-0.41	$-0.40	4
2025	$-0.42	$-0.39	$-0.37	3
2026	$-0.29	$-0.27	$-0.26	4
2027	$-0.27	$-0.25	$-0.24	4
2028	$-0.26	$-0.24	$-0.22	2
2029	$-0.12	$-0.11	$-0.10	1

MaxCyte, Inc. (MXCT) forecast — frequently asked questions

What is the analyst price target for MaxCyte, Inc.?

Analysts covering MaxCyte, Inc. (MXCT) have a consensus price target of $6.00, 328.6% above the current price of $1.40. Published targets range from $6.00 to $6.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for MaxCyte, Inc.'s earnings?

The average analyst estimate for MaxCyte, Inc. (MXCT) earnings per share in 2029 is -0.11, with individual estimates between -0.12 and -0.10.

How much revenue is MaxCyte, Inc. expected to make?

Analysts forecast MaxCyte, Inc. (MXCT) revenue of $81.50T in 2029, based on 1 published estimates.

How many analysts cover MXCT?

4 analysts contribute estimates for MaxCyte, Inc. (MXCT). Thin coverage makes an average less reliable.

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.